ProPhase Labs, Inc. Competitors

PRPH 
$1.44
*  
0.01
0.69%
Get PRPH Alerts
*Delayed - data as of Sep. 23, 2014 12:55 ET  -  Find a broker to begin trading PRPH now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PRPH Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Competitor Industry: Major Pharmaceuticals

ProPhase Labs, Inc.
CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Dicerna Pharmaceuticals, Inc.
DRNA: NASDAQ-GS
$ 13.53 0.51 ▲ 68,080 $ 13.58
$ 12.65
$ 46
$ 12.64
NE 240,414,570
Dipexium Pharmaceuticals, Inc.
DPRX: NASDAQ-CM
$ 10.28 unch 500 $ 10.28
$ 10.28
$ 15.86
$ 8
NE 87,770,640
Dr. Reddy's Laboratories Ltd
RDY: NYSE
$ 52.08 0.20 ▲ 175,101 $ 52.20
$ 51.77
$ 52.64
$ 37.49
23.15 1,636,041,120
Durata Therapeutics, Inc.
DRTX: NASDAQ-GM
$ 13.904 0.47 ▲ 153,585 $ 13.995
$ 13.25
$ 18.17
$ 8.44
NE 372,307,408
Durect Corporation
DRRX: NASDAQ-GM
$ 1.52 unch 98,835 $ 1.5375
$ 1.515
$ 2.69
$ 1.20
NE 169,627,440
Dynavax Technologies Corporation
DVAX: NASDAQ-CM
$ 1.41 -0.01 ▼ 393,379 $ 1.41
$ 1.37
$ 2.14
$ 1.10
NE 370,662,210
Eagle Pharmaceuticals, Inc.
EGRX: NASDAQ-GM
$ 12.05 -0.18 ▼ 10,149 $ 12.13
$ 11.878
$ 16.44
$ 9.16
NE 168,941,000
Egalet Corporation
EGLT: NASDAQ-GM
$ 9.57 -0.11 ▼ 2,859 $ 9.7616
$ 9.57
$ 19.85
$ 8.74
NE 165,407,880
Eleven Biotherapeutics, Inc.
EBIO: NASDAQ-GM
$ 12.0663 0.01 ▲ 481 $ 12.0663
$ 12.0663
$ 19.3326
$ 9.502
NE 196,354,900
Eli Lilly and Company
LLY: NYSE
$ 65.89 -0.19 ▼ 1,061,890 $ 66.12
$ 65.50
$ 67.14
$ 47.53
20.98 73,619,424,120
Emergent Biosolutions, Inc.
EBS: NYSE
$ 21.53 -0.16 ▼ 44,047 $ 21.68
$ 21.18
$ 28.48
$ 17.31
61.51 806,879,810
Enanta Pharmaceuticals, Inc.
ENTA: NASDAQ-GS
$ 38.68 -0.05 ▼ 71,137 $ 39.08
$ 38.1175
$ 46.443
$ 18.31
21.73 718,790,440
Endo International plc
ENDP: NASDAQ-GS
$ 67.05 0.89 ▲ 788,158 $ 67.15
$ 65.43
$ 82.16
$ 43.12
NE 10,290,163,500
Endocyte, Inc.
ECYT: NASDAQ-GS
$ 7.40 0.41 ▲ 1,202,596 $ 7.68
$ 7.09
$ 33.70
$ 5.91
27.41 307,477,400
EPIRUS Biopharmaceuticals, Inc.
EPRS: NASDAQ-CM
$ 7.39 0.24 ▲ 17,269 $ 8.20
$ 7.26
$ 82.7983
$ 7.15
NE 95,530,530
Epizyme, Inc.
EPZM: NASDAQ-GS
$ 25.475 -0.03 ▼ 86,554 $ 26.0391
$ 25.22
$ 42.71
$ 18.10
NE 855,552,400
ERBA Diagnostics, Inc.
ERB: AMEX
$ 3.42 -0.04 ▼ 15,056 $ 3.46
$ 3.36
$ 4.13
$ 1.22
171 150,079,860
Esperion Therapeutics, Inc.
ESPR: NASDAQ-GM
$ 16.20 0.03 ▲ 5,682 $ 16.46
$ 16.16
$ 19.55
$ 10.90
NE 250,209,000
Evoke Pharma, Inc.
EVOK: NASDAQ-CM
$ 5.76 0.05 ▲ 12,722 $ 5.85
$ 5.56
$ 14.25
$ 4.95
NE 35,136,000
Fibrocell Science Inc
FCSC: NASDAQ-CM
$ 3 -0.02 ▼ 38,105 $ 3.07
$ 2.95
$ 6.30
$ 2.60
NE 122,571,000
Five Prime Therapeutics, Inc.
FPRX: NASDAQ-GS
$ 12.15 0.54 ▲ 97,188 $ 12.22
$ 11.50
$ 23.33
$ 8.02
NE 261,480,150
Flamel Technologies S.A.
FLML: NASDAQ-GM
$ 14.81 unch 47,827 $ 14.88
$ 14.70
$ 15.96
$ 5.30
NE 566,749,080
Flexion Therapeutics, Inc.
FLXN: NASDAQ-GM
$ 16.70 -0.66 ▼ 12,953 $ 17.3999
$ 16.70
$ 21.23
$ 11.06
NE 260,920,800
Galectin Therapeutics Inc.
GALT: NASDAQ-CM
$ 5.09 -0.15 ▼ 151,224 $ 5.40
$ 5.01
$ 19.1099
$ 4.28
NE 112,198,870
Galectin Therapeutics Inc.
GALTU: NASDAQ-CM
$ 11.99 -2.56 ▼ 200 $ 12.20
$ 11.99
$ 54.06
$ 11.35
NE 13,896,410